首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2736篇
  免费   136篇
  国内免费   17篇
耳鼻咽喉   50篇
儿科学   40篇
妇产科学   39篇
基础医学   317篇
口腔科学   38篇
临床医学   197篇
内科学   830篇
皮肤病学   118篇
神经病学   243篇
特种医学   53篇
外国民族医学   25篇
外科学   245篇
综合类   4篇
一般理论   1篇
预防医学   294篇
眼科学   13篇
药学   163篇
中国医学   10篇
肿瘤学   209篇
  2023年   22篇
  2022年   43篇
  2021年   103篇
  2020年   63篇
  2019年   95篇
  2018年   102篇
  2017年   52篇
  2016年   71篇
  2015年   56篇
  2014年   122篇
  2013年   166篇
  2012年   197篇
  2011年   244篇
  2010年   134篇
  2009年   96篇
  2008年   175篇
  2007年   157篇
  2006年   159篇
  2005年   160篇
  2004年   129篇
  2003年   131篇
  2002年   106篇
  2001年   28篇
  2000年   32篇
  1999年   28篇
  1998年   18篇
  1997年   19篇
  1996年   17篇
  1995年   8篇
  1994年   8篇
  1993年   6篇
  1992年   14篇
  1991年   13篇
  1990年   6篇
  1989年   6篇
  1988年   9篇
  1987年   7篇
  1986年   8篇
  1985年   11篇
  1984年   13篇
  1983年   7篇
  1982年   8篇
  1981年   4篇
  1979年   6篇
  1978年   4篇
  1972年   3篇
  1971年   4篇
  1970年   2篇
  1968年   3篇
  1967年   2篇
排序方式: 共有2889条查询结果,搜索用时 15 毫秒
31.
32.
Risperidone is a potent antagonist of both dopamine and serotonin receptors. However, little is known about the underlying molecular mechanism by which risperidone acts. Although a number of genetic variants have been observed to correlate with treatment response there are no definitive predictors of response. We performed a genome-wide gene expression analysis (Human Genome U219 Array Plate) of a human neuroblastoma cell line (SK-N-SH) exposed to risperidone to identify molecular mechanisms involved in the cellular response to risperidone and thus identify candidate genes for pharmacogenetic studies. Our results revealed that cellular risperidone treatment is associated with a range of gene expression changes, which are time (6–48 h) and dose related (0.1–10 μM). We found that functional clusters of these changes correspond to Gene Ontology categories related to neural cell development functions, and synaptic structure and functions. We also identified Canonical Pathways related to these functional categories: neurogenesis and axon guidance; synaptic vesicle; and neurotransmitter signaling (dopamine, serotonin and glutamate). Finally, we identified candidate genes for pharmacogenetic studies related to the main risperidone secondary effects: motor disorders, cardiovascular disorders and metabolic disorders. Our results suggest that risperidone treatment affects the neurogenesis and neurotransmission of neuroblastoma cells, which is in agreement with the “initiation and adaptation” model to explain the mechanism of action of psychotropic drugs.  相似文献   
33.
34.
BackgroundPatients with a first episode of psychosis (FEP) are at higher risk of gaining weight and presenting metabolic disturbances, partly related to antipsychotic exposure. Previous studies suggest that treatment discontinuation might have a positive impact on weight in schizophrenia. The aim of this study was to evaluate the effect of treatment discontinuation on weight and metabolic changes in a FEP cohort.MethodsA total of 209 FEP patients and 57 healthy controls were evaluated at study entry and prospectively at 10-year follow-up. Anthropometric measures and, clinical, metabolic, and sociodemographic data were collected.ResultsPatients discontinuing antipsychotic treatment presented a significantly lower increase in weight and better metabolic parameter results than those still on antipsychotic treatment at 10-year follow-up.ConclusionsTreatment discontinuation had a positive effect on the weight and metabolic changes observed in FEP patients; however, this effect was not sufficient to reaching a complete reversal to normal levels.  相似文献   
35.
36.
37.
38.
39.
40.
Huntington''s disease (HD) is a neurodegenerative disorder caused by a mutation in the gene encoding the huntingtin protein. Although the precise mechanism by which neuronal degeneration occurs is still unclear, several elements are important to its development: (1) altered gene expression and protein synthesis, (2) mitochondrial damage and (3) improper regulation of the autophagy programme. In this issue of British Journal of Pharmacology, Galindo and co-workers provide the first evidence for a role of the mitochondrial permeability transition pore (mPTP) in mitochondrial fragmentation and autophagy activation. In a model of cell death induced by 3-nitropropionic acid (3-NP) in human neural cells, the authors describe clear functions for mPTP and Bax, but not the mitochondrial fusion/fission machinery, mitochondrial fragmentation and autophagy (mitophagy). This commentary summarises the significance of this relationship and suggests several points for future development.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号